FDA & CDC Authorize COVID-19 Boosters for Eligible Individuals
Boosters have been approved for all 3 COVID-19 vaccines (Pfizer, Moderna and Johnson & Johnson).
Schedule an appointment today.
The FDA and CDC have authorized COVID-19 boosters for Pfizer, Moderna and Johnson & Johnson recipients who meet the below criteria. See below for information on boosters as well as additional doses for moderately to severely immunocompromised individuals.
Boosters can be administered at least 5 months after the 2nd dose of an initial series of Pfizer for individuals 12 years or older. Individuals 12-17 are eligible only for a Pfizer booster dose (no mixing and matching). Ages 50+ (and certain immunocompromised individuals) may receive a second booster at least 4 months after their previous booster. Online scheduling for second boosters coming soon; walk-ins welcome now.
Boosters can be administered at least 5 months after the 2nd dose of an initial series of Moderna or individuals 18 years or older. Moderna boosters will be administered at a half-dose volume compared to the initial series. Ages 50+ (and certain immunocompromised individuals) may receive a second booster at least 4 months after their previous booster. Online scheduling for second boosters coming soon; walk-ins welcome now.
Johnson & Johnson/Janssen:
Boosters can be administered at least 28 days after the initial Johnson & Johnson/Janssen shot was administered for anyone age 18+. mRNA boosters (Pfizer or Moderna) are recommended over an additional dose of Johnson & Johnson/Janssen. For more information on second boosters, visit the CDC website.
Can I choose a different vaccine for a booster (mix and match):
The CDC recommends an mRNA (Pfizer or Moderna) vaccine for your booster. You can request the vaccine for your booster when scheduling your appointment. Individuals 12-17 years old may receive only a Pfizer booster.
Additional Doses for Immunocompromised
To meet the qualifications for an additional dose:
Individuals must have received the original series of either Pfizer or Moderna COVID-19 vaccine at least 28 days prior
AND be considered moderately to severely immunocompromised as defined below:
Had a solid organ transplant or recent hematopoietic malignancies
Active or recent treatment for solid tumor hematologic malignancies (cancer)
Severe primary immunodeficiency
Advanced or untreated HIV
Active treatment with high dose corticosteroids, alkylating agents, antimetabolites, TNF blockers, and other biologic agents
Asplenia and chronic renal disease can be considered if condition is severe
*Note: Customers can self-attest to being moderately or severely immunocompromised and should not be asked to provide documentation or turned away for an additional dose if they do not provide documentation.
Third doses can be administered to Pfizer recipients ages 5+ or Moderna recipients ages 18+. Online scheduling for 3rd doses for immunocompromised individuals 5-11 available now.
Moderately to severely immunocompromised individuals have been approved for a booster shot 3 months after a Pfizer 3rd dose for individuals ages 12+ or 3 months after a Moderna 3rd dose for individuals ages 18+. Online scehduling for these boosters is now available. Your pharmacist can answer additional questions about booster eligibility at your appointment.
For eligible individuals, please schedule an appointment today.